Ketamine is a dissociative anesthetic that has been safely used in medical settings for decades. Its complicated public reputation stems mainly from its history as a recreational drug, along with the media attention that history has received, rather than from its clinical use.

But here’s the short answer: When administered by trained medical professionals in a monitored clinical setting, ketamine therapy is safe. 

Below, we break down what the clinical research shows, how addiction risk differs in a supervised setting compared with recreational use, and how patient safety guides every aspect of care at Keta Medical Center — from sessions supervised by medical staff to clinical treatment protocols.

Is ketamine therapy safe?

Yes. Across decades of clinical use and hundreds of registered clinical trials for depression, there have been no reported deaths and no serious cardiac events tied to individuals receiving sub-anaesthetic ketamine for psychiatric disorders in a supervised medical setting. 

That safety record exists alongside a very different reputation in the public eye. Media coverage of ketamine has often focused on recreational misuse or on deaths linked to unsupervised, unregulated use, sometimes at doses and purity levels far outside anything used in medical care. 

The risks associated with illicit ketamine use, whether from contamination, unknown dosing, or lack of medical oversight, are not the same risks present when ketamine is administered by trained physicians in a monitored clinical setting like at Keta Medical Center.

Ketamine has also become one of the most extensively studied treatments for depression over the past two decades, the subject of thousands of scientific papers and hundreds of registered clinical trials, and it’s referenced by major medical organizations that oversee psychiatric treatment standards. 

Ketamine’s safety profile has also been studied against other established treatments. A study comparing ketamine with electroconvulsive therapy (ECT) for treatment of depression found that ketamine was associated with fewer adverse events than ECT (25.1% versus 32.4%), along with less impact on memory recall. Ketamine was also found to be non-inferior to ECT, with 55% of patients responding to treatment compared to 41% in the ECT group.

Randomized, placebo-controlled trials have repeatedly found that ketamine can rapidly reduce depressive symptoms in patients with treatment-resistant depression. In a large clinical study of this population, nearly 70% of patients on Spravato® achieved a clinical response and more than half achieved remission, with long-term follow-up showing 46% remained in remission after up to 4.5 years of maintenance treatment, with no new safety concerns identified over that period.

Is it safe to use ketamine at home?

Not in the way it’s often marketed, and this is where much of ketamine’s dangerous reputation actually comes from. A number of telehealth companies now ship compounded ketamine lozenges or troches directly to patients for unsupervised, at-home use, and that’s a fundamentally different practice from clinic-based ketamine therapy.

In October 2023, the FDA warned that these products are not FDA-approved for any psychiatric use and that taking them without a health care provider monitoring for sedation, dissociation, and changes in vital signs puts patients at risk. Several hospitalizations and deaths tied to unsupervised at-home use, including a widely reported case involving actor Matthew Perry, have reinforced that warning, and a case report published in the American Journal of Psychiatry documented a patient who suffered an unintentional overdose after receiving inconsistent instructions from a telehealth provider during at-home treatment.

Patients deserve to hear this plainly: the safety record in this article describes ketamine given on-site by trained staff, not mail-order ketamine used alone at home. News coverage rarely draws that line, so people assume medical ketamine is the danger, when the real common thread is no supervision. At Keta Medical Center, every dose is given on-site, under direct clinical supervision, and that’s what sets us apart from the headlines.

Is ketamine addictive in a clinical setting?

When ketamine is administered in a medically supervised setting, the risk of developing addiction is extremely low, and there have been no published reports of addiction developing within clinical trials for depression. Long-term follow-up studies also have not found evidence of physical dependence, even months or years after treatment ended. 

This differs significantly from recreational ketamine use, which may involve frequent exposure, larger or unpredictable doses, and no medical oversight. Although ketamine can be misused and addiction remains possible, the risk in a properly screened and monitored patient is substantially different from the risk associated with unsupervised use. 

The DEA classifies ketamine as a Schedule III controlled substance. This means it has an accepted medical use but also carries the potential for misuse and psychological or physical dependence. Its controlled-substance status is one reason appropriate patient screening, careful dosing, ongoing monitoring, and administration by qualified medical professionals are essential. 

How Keta Medical Center creates a safe, supportive environment

Safety at Keta Medical Center starts well before a single dose is administered. Every patient goes through a thorough intake evaluation with our clinical team, covering medical history, current medications, cardiovascular risk factors, and any past experience with substance use. This process helps us determine whether ketamine therapy is a suitable fit within a broader, personalized treatment plan.

Treatment itself takes place in a private room, supervised throughout by experienced emergency medicine physicians. For IV ketamine infusions, a typical session lasts approximately 40 minutes to an hour, and patients are monitored for safety and comfort for about 90 minutes in total. Vital signs, including heart rate, blood pressure, and oxygen levels, are tracked throughout the infusion.

For Spravato (esketamine) nasal spray, patients are monitored on-site by the medical team for at least two hours after each dose, with blood pressure, heart rate, and oxygen levels checked at the beginning, 40 minutes post-dose, and at the end.

What side effects can patients expect?

During treatment, ketamine produces a temporary dissociative state, a sense of altered perception or detachment from one’s surroundings. This is a known and expected effect of the medication at therapeutic doses, and it resolves as the infusion or nasal spray session ends.

In a review of Spravato safety data collected over 12 months of treatment, the most common side effects during the first week of treatment were dizziness (20.6%), dissociation (16.7%), nausea (14%), vertigo (12.1%), increased blood pressure (4.3%), and sedation (3.8%), and each of these decreased in frequency with continued treatment. 

Most patients feel back to their baseline well before they leave our clinic.

Who should avoid ketamine therapy?

Ketamine therapy is not appropriate for everyone. It’s generally not recommended for people with certain cardiovascular conditions (including uncontrolled hypertension or aneurysmal vascular disease), a history of intracerebral hemorrhage, an arteriovenous malformation, a history of psychosis, an active substance use disorder, or other contraindications that a physician would need to evaluate individually. Patients who are pregnant or planning to become pregnant should also discuss this with their care team.

For a closer look, see our article: Who Is a Good Candidate for Ketamine Therapy?

Talk with our clinical team

If you are deciding whether ketamine therapy may be a safe option for you, the most reliable next step is a conversation with a licensed clinician who can review your medical history and answer your specific questions. Our team is here to walk you through what to expect, from intake through monitoring, so you can make an informed decision about your care.

Book a free consultation.

FAQs

Why is ketamine treatment in a clinical environment considered safe?

Every session takes place under direct physician supervision, with a clinical team monitoring your vitals throughout treatment. Before your session begins, our team reviews your medical history, checks your vitals, and confirms you’re ready to proceed. Dosing follows medically supervised, evidence-based protocols, and staff are present to respond immediately if any issues arise.

What if I feel scared or overwhelmed during a session?

It’s normal to feel a little nervous, especially before your first session. Our clinical team prepares you in advance for what a ketamine session may feel like. A member of our medical team is available throughout, and you can speak up at any point if you feel anxious or need reassurance. Our staff is trained to respond quickly and calmly to support you during the experience.

Will someone be with me the entire time, or am I on my own during treatment?

You are never on your own. An experienced medical team, led by emergency medicine physicians, is right outside your treatment room throughout the session, periodically checking in on your heart rate, blood pressure, and oxygen levels. If anything about your vitals or how you’re feeling needs attention, our clinical team is close by and ready to respond.

Do I need someone to drive me home after treatment?

Yes. Ketamine and Spravato can affect coordination, alertness, and reaction time well after your session ends, so you should not drive yourself home. For Spravato treatment, the FDA advises against driving or operating machinery until the next day, after a full night of restful sleep. 

What happens if my vitals change during a session?

Small, temporary changes in blood pressure or heart rate are a normal part of ketamine treatment, and serious complications are rare. Even so, your heart rate, blood pressure, and oxygen levels are monitored throughout every session, whether you’re receiving an IV ketamine infusion or Spravato nasal spray. Because our clinical team includes experienced emergency medicine physicians, any changes are identified early and managed calmly and quickly, right in the treatment room.

The post Is Ketamine Therapy Safe? What Patients Should Know appeared first on Keta Medical Center.

In anesthesia, we call this process emergence.

I never imagined that one of my most profound experiences of emergence would involve an anesthetic itself.

That anesthetic is ketamine.

Ketamine has been safely used as an anesthetic for decades. More recently, it has also emerged as an important tool in the treatment of certain mental health conditions, including treatment-resistant depression and PTSD. What makes this especially meaningful to me is that I know these struggles not only as a physician, but also from personal experience.

The wounds we carry

All of us experience trauma in some form. Some experiences are what we might call “little t” traumas; others are profound, life-altering events. Regardless of how we label them, painful experiences can leave lasting emotional wounds.

Healing does not necessarily mean erasing those experiences. The scars may remain. But the wounds can heal.

When painful experiences overwhelm us, we often develop ways of protecting ourselves. We suppress emotions. We avoid difficult feelings. We disconnect from painful memories. We tell ourselves that we are fine and keep moving forward.

For me, that became my coping mechanism.

I learned to suppress my emotions, avoid uncomfortable feelings, and, in a sense, anesthetize myself emotionally.

At first, this worked. Avoidance can be remarkably effective in the short term. But what protects us temporarily can eventually prevent us from healing.

Learning about emergence

During my residency in anesthesiology, one of my senior attendings taught me something that stayed with me: every patient who goes under anesthesia must eventually emerge.

In the controlled environment of the operating room, we can temporarily eliminate pain, support vital functions, and carefully maintain the body’s equilibrium. But anesthesia is not the destination. Eventually, the patient must awaken. The body must resume its normal functions, and the process of reconnecting with the world begins.

Years later, I began to understand that this was true emotionally as well.

I had spent a great deal of my life trying not to feel certain things. Eventually, that strategy stopped working. Depression began to take hold, and I gradually came to recognize something that was difficult for me to admit:

I needed help.

I worked with several psychiatrists and therapists and tried numerous medications, but I continued to struggle. Then I learned about ketamine.

I remember approaching treatment with something close to hopelessness and the thought, What do I have to lose?

That brought me to Keta Medical Center.

Opening the door

My treatment with esketamine, also known as Spravato, together with the support of the medical and therapy team at Keta Medical Center, became an important part of my journey.

The experience did not simply make everything better overnight. Rather, it seemed to loosen some of the defenses I had built over the years. Things that had once felt too difficult to approach became a little more accessible.

And that is where the real work began.

Working with a therapist I trusted, I began exploring some of the experiences and emotions I had spent years avoiding. Through that process, it became increasingly clear that unresolved trauma and symptoms of PTSD were contributing to my depression.

Recognizing that connection changed the direction of my treatment.

Going where I had been afraid to go

Because trauma can become deeply embedded in the way we experience memories and emotions, another therapeutic approach was recommended: EMDR, or Eye Movement Desensitization and Reprocessing.

EMDR is a psychotherapy approach designed to help people process distressing memories so that those experiences can become less emotionally overwhelming and less likely to feel as though they are happening all over again.

For me, the combination of ketamine treatment and trauma-focused therapy created an opportunity to approach difficult material differently.

Ketamine did not do the work for me.

It helped open the door. Therapy helped me walk through it.

That distinction is important.

Exploring painful experiences requires patience, trust, and a sense of safety. I have approached that darker territory slowly and cautiously, surrounded by people I trust and in an environment where I feel supported.

Emerging

My journey is still unfolding.

I don’t think healing means that we forget what happened to us. And I don’t believe that becoming whole requires pretending that our painful experiences never occurred.

Instead, I am learning to acknowledge what happened without allowing it to control me.

We can all carry scars but we don’t have to live inside the wound.

After nearly four decades of putting patients to sleep and helping them awaken, I have come to appreciate the meaning of emergence in a completely different way.

Sometimes, we spend years anesthetizing ourselves from the things that hurt.

And sometimes, healing begins when we finally allow ourselves to wake up.

As Peter Gabriel sings in Digging in the Dirt, there is something powerful about being willing to explore and find the places where we’ve been hurt. For me, that journey has meant having the courage to look beneath the surface—to acknowledge what I had buried, to understand how it shaped me, and to begin finding a way forward.

The post Emergence: From Anesthetizing to Healing: My Journey with Ketamine Therapy appeared first on Keta Medical Center.

We’ve pulled together the most helpful questions from that conversation below, along with expanded answers. If you’d like to see the full discussion, including the community’s questions and follow-up comments, you can read it in its entirety on Reddit here.

Top questions from our Ask Me Anything

What types of patients are not well suited for ketamine therapy?

Candidacy for ketamine therapy depends on a person’s full medical and psychiatric history, which is why every prospective patient completes a medical intake before starting treatment. Some psychiatric conditions can rule a patient out entirely. People with schizophrenia, active psychosis or active mania are not good candidates, since ketamine can worsen these conditions. Additionally, uncontrolled high blood pressure and a history of aneurysm may disqualify someone from treatment. Dr. Malina conducts a one-on-one consultation with each potential patient to determine whether ketamine therapy is an appropriate option.

For a deeper dive, check out our article, “Who is a Good Candidate for Ketamine Therapy?”

Is there a set ketamine treatment schedule, or does it vary by patient?

There’s a set induction phase, and it’s not arbitrary. The standard IV ketamine induction is 6 infusions, based on repeated infusion protocols studied in clinical trials for depression. Spravato follows its own FDA-approved induction schedule: twice weekly for 4 weeks, or 8 treatments total.

What varies is what happens after induction. Once you complete the initial series, your provider evaluates your response and builds a maintenance schedule around it, which could mean sessions every few weeks or longer, depending on how you’re doing.

How many psychiatrists does Keta Medical Center employ, and how does the clinical team work together?

Ketamine therapy works best as part of a coordinated, multidisciplinary approach, so it’s worth explaining how our clinical team is structured. Keta Medical Center’s psychiatric team currently includes two board-certified psychiatrists and two psychiatric nurse practitioners (PMHNPs), working alongside eight therapists, providing therapy virtually and in-person across our locations.

These roles are related but distinct. Psychiatrists are medical doctors who complete a residency in psychiatry and are trained to independently diagnose and manage complex psychiatric conditions, including prescribing and adjusting medication. Psychiatric nurse practitioners complete graduate-level training in psychiatric and mental health care and are licensed to evaluate, diagnose, and manage many of the same conditions.  Both play an important role in patient care, and we’re transparent about which type of clinician a patient is working with.

Because Keta Medical Center operates across multiple locations, our psychiatric team and therapists are shared clinical resources rather than being assigned to a single center. This allows every patient, regardless of which location they visit, to have access to psychiatric evaluation and therapy, whether through our in-house team or in coordination with a psychiatrist or therapist a patient already sees outside our practice.

Separately, the nurses who supervise ketamine infusions and Spravato® sessions in-office are emergency medicine trained, since they are well equipped to monitor vitals such as blood pressure and pulse throughout treatment and help patients manage any side effects.

Diagnosis, ongoing psychiatric care planning, and medication management are handled by our psychiatric team, while medical administration and safety monitoring during sessions are handled by our on-site physicians and nurses. For current details on individual clinicians’ credentials and experience, visit our Meet the Team page.

Is Spravato covered by insurance, and what about ketamine infusions?

Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and is covered by many insurance plans, including Medicare. Our intake and billing team manages prior authorizations and payment assistance programs on behalf of patients to make the process as smooth as possible.

Ketamine infusions are a different story. Because IV ketamine is used off-label (meaning the FDA hasn’t specifically approved IV ketamine for this use, even though the drug itself is FDA-approved for other purposes), it’s generally not covered by insurance and is a private-pay treatment. At Keta Medical Center, ketamine infusion sessions are $500 each, which includes two hours in a private room supervised by an emergency medicine physician and a nurse. Most patients complete six sessions during the initial induction phase. We accept CareCredit and flexible spending cards to help make treatment more accessible.

How does Keta Medical Center address bladder-related side effects?

Bladder issues linked to ketamine use have been documented in cases of unsupervised, recreational use— not in medically-supervised treatment. While it is a recognized side effect, it is usually self limited and doesn’t cause long term issues in patients without underlying bladder disease.

At Keta Medical Center, we reduce this risk through careful patient screening, physician-oversight and appropriate dosing and treatment intervals: evidence-informed protocols for ketamine infusions, which are used off-label for psychiatric conditions, and the FDA-mandated monitoring requirements that apply specifically to Spravato.

That said, patients with an existing bladder condition, such as interstitial cystitis, need urologic clearance before beginning treatment. This is one of the many factors we review during the medical intake process to help confirm ketamine therapy is a safe fit.

How addictive is ketamine, and how is that risk managed?

When ketamine is administered under medical supervision with appropriate dosing and treatment intervals, addiction risk has been shown to be very low. Spravato is FDA-approved and administered under a Risk Evaluation and Mitigation Strategy (REMS) program with specific monitoring requirements.

Ketamine infusions, are used off-label for psychiatric conditions but its effectiveness is well-researched . We follow medically supervised, evidence-informed protocols. We also build in ongoing check-ins with patients, and with their psychiatrists when applicable, to reassess treatment goals and adjust the visit schedule as needed over time.

What’s the difference in dosing between ketamine infusions and Spravato?

Because IV ketamine and Spravato are administered differently, their dosing differs as well. Ketamine infusions are weight-based, while Spravato uses standard dosing regardless of a patient’s weight. A ketamine infusion typically runs about 45 minutes plus recovery time, while Spravato visits last two hours, a timeline mandated by the FDA. Eight of Keta Medical Center’s nine locations currently offer IV ketamine infusions.

What happens after completing a Spravato induction series?

Once a patient completes the initial induction phase, next steps depend on how they’re responding to treatment. Some patients find that their symptoms have stabilized and no longer need ongoing sessions. Others continue with less frequent visits, described as booster sessions for IV ketamine and maintenance sessions for Spravato, to help maintain their progress. Because everyone’s treatment goals evolve differently, we work with each patient individually, and with their psychiatrist when applicable, to determine the right interval going forward.

How does ketamine therapy compare to electroconvulsive therapy for treatment-resistant depression?

Comparative research has found ketamine to be an effective, less invasive option relative to electroconvulsive therapy (ECT) for treatment-resistant depression, generally with an easier recovery and without some of the long-term side effects associated with ECT, such as memory loss.

Can ketamine therapy help with complex post-traumatic stress disorder?

Ketamine appears to support recovery from complex post-traumatic stress disorder (cPTSD) in part through its effect on neuroplasticity, the brain’s ability to form new neural pathways. This process can help patients reframe old memories or triggers rather than remaining locked into familiar response patterns. Pairing ketamine treatment with therapy is an important part of making these new patterns lasting.

Is ketamine therapy effective for obsessive-compulsive disorder?

Spravato is not a direct treatment for obsessive-compulsive disorder (OCD) itself, but it can help by targeting the depression that often accompany or contributes to OCD symptoms. Many patients describe feeling less “stuck” in compulsive patterns after treatment. As with other conditions, pairing ketamine with therapy tends to produce the most meaningful and lasting results.

Can ketamine therapy help reduce alcohol cravings?

Several published studies suggest ketamine may help reduce alcohol cravings and reliance in people working to change their relationship with alcohol, and this pattern has also been reported anecdotally among our own patients. As with other applications, ketamine tends to work best as part of a broader plan that includes therapy and other forms of support rather than as a standalone solution.

What is a “K-hole,” and how is that different from medical ketamine treatment?

A “K-hole” is a slang term describing an intense state of dissociation, typically associated with high, unsupervised doses of ketamine taken recreationally, sometimes in combination with other substances. It is not a medical diagnosis. In a supervised clinical setting, dosing is calculated according to established medical protocols, and the resulting dissociative effect is milder and short-lived, resolving before a patient leaves the office.

Are there special considerations for patients who have diabetes?

There are no specific concerns for people who have diabetes receiving ketamine therapy. The main adjustment is that patients are asked not to eat or drink for one hour before treatment, so diabetic patients may need to plan their insulin or meal timing around that window in coordination with their endocrinologist. We treat many patients who have diabetes and work with each person individually to plan around their needs.

Wrapping up

We loved seeing everyone show up with such thoughtful, insightful questions during our AMA. It’s clear how much this community cares about finding real answers, and we’re grateful for the chance to help provide them. If you still have questions we didn’t get to, or anything else comes to mind, don’t hesitate to reach out to our team here.

Ketamine therapy is not the right fit for everyone, and determining candidacy depends on individual history and treatment goals. If you’re considering whether ketamine infusions or Spravato might be appropriate for you, connect with our clinical team for a consultation.

Book a consultation.

The post What Prospective Patients Wanted to Know About Ketamine Therapy: Our Reddit AMA Recap appeared first on Keta Medical Center.

The post Is Ketamine Therapy Covered by Insurance? How Keta MC Helps at Every Step appeared first on Keta Medical Center.

If you’re considering ketamine therapy for depression, one of the first questions you probably have is how many sessions it takes to see results. The answer depends in part on which treatment option you choose.

At Keta Medical Center, we offer both Spravato and IV ketamine. Spravato is the brand name for esketamine, a nasal spray version of ketamine therapy administered under medical supervision. Most patients complete eight Spravato sessions over four weeks, or six IV ketamine infusions over three weeks, for their induction phase. From there, maintenance sessions continue on a schedule tailored to you.

Below, we break down what a typical course of treatment looks like for our two main options: IV ketamine and Spravato (esketamine nasal spray).

How ketamine treatment plans are structured for depression

Most ketamine protocols follow these phases:

• Induction phase: A concentrated series of sessions delivered close together, designed to build a therapeutic response.
• Optimization phase (Spravato): Once the induction series is complete, Spravato patients move into an optimization phase, with less frequent follow-up sessions.
• Maintenance phase (IV ketamine and Spravato): Both treatment types then continue into a maintenance phase, with follow-up sessions spaced out further to sustain improvement over time.

Treatment Timeline

IV Ketamine Spravato

Intake:

Medical & bio-psycho-social assessment

Week 0 ASSESSMENT

Preparation session

Set intentions with therapist

Ketamine infusion

2x a week

Weeks 1-3 INDUCTION

Integration therapy

1x a week

Ketamine infusion

Every 4 weeks, or according to your personalized plan

Week 4 & beyond MAINTENANCE

Integration therapy

As needed

Intake:

Medical & bio-psycho-social assessment

Week 0 ASSESSMENT

Preparation session

Set intentions with therapist

Nasal spray

2x a week

Month 1 INDUCTION

Integration therapy

1x a week

Nasal spray

1x a week

Month 2 OPTIMIZATION

Integration therapy

1x a week

Maintenance

Every 1-2 weeks, or according to your personalized plan

Month 3 & beyond MAINTENANCE

Integration therapy

As needed

The post How Many Ketamine Treatments Are Needed for Depression? appeared first on Keta Medical Center.

 

Our clinicians evaluate all of these factors when developing a personalized treatment plan. No two patients’ timelines are identical, and results will vary.

Ketamine therapy at Keta Medical Center

At Keta Medical Center, ketamine therapy is administered under the supervision of experienced emergency medical physicians in a private, spa-like setting designed to support patient comfort and safety. We take a thorough, individualized approach, from the intake evaluation through the final follow-up, to ensure that every patient’s care is thoughtfully calibrated to their needs.

We offer both intravenous ketamine infusions and Spravato for eligible patients. Spravato is FDA-approved for treatment-resistant depression, while IV ketamine is used off-label for a range of conditions, including PTSD, anxiety, bipolar depression, postpartum depression, OCD, and others. Our team will assess which option is most appropriate during your consultation.

Beyond physician-led ketamine therapy, Keta Medical Center also offers psychiatry and therapy services, meaning care can be tailored to your full picture rather than a single treatment approach. We actively monitor evolving research on ketamine to ensure our protocols reflect the current state of the evidence.

If you are living with a condition that has not responded to conventional treatment and want to understand whether ketamine therapy may be appropriate for you, we encourage you to speak with our clinical team.

Book a free consultation

FAQs

How long does the dissociative experience last?

The temporary dissociative state, a mild sense of altered perception or detachment, typically lasts for the duration of the infusion (around 45 minutes) and may continue for an hour or two after the session ends. 

How quickly can ketamine relieve depression symptoms?

Ketamine can begin to produce meaningful antidepressant effects within days. A randomized controlled trial found significantly greater reductions in depression severity 24 hours after a single ketamine infusion compared to placebo, with response rates more than double those seen with placebo.

How long do the antidepressant effects of ketamine last?

After a single infusion, many patients who respond report symptom relief lasting approximately 7 to 14 days, though individual results vary. A structured series of infusions is associated with more sustained outcomes. Maintenance sessions for Spravato or booster sessions for IV ketamine can help extend the benefit further. 

How long does ketamine stay in the body?

Ketamine has a half-life of approximately 2 to 3 hours and is effectively cleared from the bloodstream within 10 to 15 hours of administration, according to NIH StatPearls. Trace metabolites may persist slightly longer. Importantly, ketamine’s therapeutic effects last well beyond the window in which the drug is detectable in the body; the two timelines are distinct.

How many ketamine infusions will I need?

The appropriate number of infusions depends on the individual and the condition being treated. Keta Medical Center evaluates each patient individually and recommends a personalized protocol, but most patients follow a structured induction phase before moving to less frequent maintenance treatment.

For IV ketamine, the standard induction series is 6 infusions over 3 weeks, followed by periodic booster infusions based on individual response.

For Spravato (esketamine), induction typically consists of 8 sessions over 4 weeks, followed by a 4-week optimization phase of 1 session per week, then a transition to an ongoing maintenance schedule.

Our clinicians will outline the recommended approach for your specific protocol and monitor your response throughout treatment.

The post How Long Does Ketamine Last? appeared first on Keta Medical Center.

The post Can Ketamine Therapy Help With Anxiety? appeared first on Keta Medical Center.

The post Ketamine Therapy Success Stories and Testimonials: Hear it From Our Patients appeared first on Keta Medical Center.

The post How Does Spravato Work? appeared first on Keta Medical Center.

The post Scrolling Your Way to Anxiety? How Social Media Impacts Mental Health appeared first on Keta Medical Center.